Characterization and Management of Adverse Reactions in Patients With Unresectable Hepatocellular Carcinoma Treated With Lenvatinib
Jones, Anna, Degregorio, Paola, Sung, Max W, Ramji, Zahra, Ren, Min, Baron, Ari D
Published in Journal of the advanced practitioner in oncology (01.11.2023)
Published in Journal of the advanced practitioner in oncology (01.11.2023)
Get full text
Journal Article
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Zhu, Andrew X, Dr, Park, Joon Oh, MD, Ryoo, Baek-Yeol, MD, Yen, Chia-Jui, MD, Poon, Ronnie, MD, Pastorelli, Davide, MD, Blanc, Jean-Frederic, MD, Chung, Hyun Cheol, MD, Baron, Ari D, MD, Pfiffer, Tulio Eduardo Flesch, MD, Okusaka, Takuji, MD, Kubackova, Katerina, MD, Trojan, Jorg, MD, Sastre, Javier, PhD, Chau, Ian, MD, Chang, Shao-Chun, MD, Abada, Paolo B, MD, Yang, Ling, MS, Schwartz, Jonathan D, MD, Kudo, Masatoshi, MD
Published in The lancet oncology (01.07.2015)
Published in The lancet oncology (01.07.2015)
Get full text
Journal Article
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
Sharma, Padmanee, Prof, Retz, Margitta, Prof, Siefker-Radtke, Arlene, MD, Baron, Ari, MD, Necchi, Andrea, MD, Bedke, Jens, Prof, Plimack, Elizabeth R, MD, Vaena, Daniel, MD, Grimm, Marc-Oliver, Prof, Bracarda, Sergio, MD, Arranz, José Ángel, MD, Pal, Sumanta, MD, Ohyama, Chikara, Prof, Saci, Abdel, PhD, Qu, Xiaotao, PhD, Lambert, Alexandre, PhD, Krishnan, Suba, MD, Azrilevich, Alex, PharmD, Galsky, Matthew D, Prof
Published in The lancet oncology (01.03.2017)
Published in The lancet oncology (01.03.2017)
Get full text
Journal Article